OPTIC NEURITIS
Clinical trials for OPTIC NEURITIS explained in plain language.
Never miss a new study
Get alerted when new OPTIC NEURITIS trials appear
Sign up with your email to follow new studies for OPTIC NEURITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Allergy drug repurposed to repair damaged nerves in vision disorder
Disease control Recruiting nowThis study is testing whether clemastine, an older allergy medication, can help repair damaged nerve coatings in people with recent optic neuritis. Researchers will enroll 90 participants who developed optic neuritis within the past 3 weeks to receive either clemastine or a place…
Matched conditions: OPTIC NEURITIS
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Race against time: early Blood-Cleansing treatment tested to save sight and mobility
Disease control Recruiting nowThis study is testing whether starting a blood-filtering treatment called plasma exchange early, versus waiting to see if it's needed later, leads to better recovery for people with severe eye nerve or spinal cord inflammation. It will enroll 382 adults who have recently develope…
Matched conditions: OPTIC NEURITIS
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug tested to halt sudden vision loss from nerve attack
Disease control Recruiting nowThis small, early-stage study is testing if adding an investigational drug called efgartigimod alfa to standard steroid treatment helps people recover vision faster from a first attack of optic neuritis. The study will enroll 20 adults who recently developed moderate to severe vi…
Matched conditions: OPTIC NEURITIS
Phase: PHASE2 • Sponsor: Anastasia Vishnevetsky, MD, MPH • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC